Buprenorphine Tablet
Product Images NDC 87441-082

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 87441-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 8 mg (8744108201 Buprenorphine 8 mg Sl)

Label for Buprenorphine Sublingual Tablets USP, 8 mg strength, for sublingual use. The label indicates prescription use only and includes storage instructions (20° to 25°C), pharmacist dispensing guidance, and repackaging details by Unit Dose Solutions, Inc. It displays the NDC code 87441-082-01 and mentions distribution by Tuckahoe Enterprises, LLC.*

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure diagram of buprenorphine hydrochloride, showing the molecular arrangement of atoms including hydroxyl, methoxy, and cyclopropyl groups characteristic to the molecule.*

FDA Label Image

Image (Buprenorphine 02)

An instructional line drawing showing a hand placing a sublingual tablet under the tongue inside an open mouth. The illustration highlights the oral cavity and tongue to demonstrate proper placement for sublingual administration of a tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.